Group One Trading
MRKR icon

Group One Trading’s Marker Therapeutics MRKR Stock Holding History

Group One Trading’s Portfolio MRKR Stock Details MRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-40
Closed -$1K – 8612
2021
Q3 		$1K Sell
40
-630
-94% -$12.9K ﹤0.01% 8026
2021
Q2 		$19K Buy
670
+310
+86% +$8.16K ﹤0.01% 7217
2021
Q1 		$8K Buy
+360
New +$8.24K ﹤0.01% 7119
2020
Q1 		– Sell
-80
Closed -$2K – 5566
2019
Q4 		$2K Buy
80
+20
+33% +$728 ﹤0.01% 4905
2019
Q3 		$3K Buy
+60
New +$3.55K ﹤0.01% 4865
2019
Q1 		– Sell
-100
Closed -$6K – 5150
2018
Q4 		$6K Buy
+100
New +$7.29K ﹤0.01% 4437

Other funds holding MRKR

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Group One Trading's MRKR Position: Q1 2026 in Review

Group One Trading held its Marker Therapeutics (MRKR) position steady in Q1 2026 at 178 shares worth $231. The position accounts for ﹤0.01% of the portfolio, ranked #7387.

Group One Trading first reported a position in MRKR in Q2 2019 and has held it in 22 quarters since. The position peaked at $70K in Q3 2019. 35 funds tracked by Wall St. Rank hold MRKR as of Q1 2026.

  • Group One Trading held 178 shares of Marker Therapeutics worth $231 as of Q1 2026.
  • Group One Trading left its Marker Therapeutics share count unchanged in Q1 2026.
  • Marker Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7387 holding.
  • Group One Trading first reported a position in Marker Therapeutics in Q2 2019 and has held it in 22 quarters since.
  • Group One Trading's Marker Therapeutics position peaked at $70K in Q3 2019.
  • 35 funds tracked by Wall St. Rank held Marker Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.